1. Home
  2. PAHC

PAHC

Phibro Animal Health Corporation

Logo Phibro Animal Health Corporation

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-18-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Founded: N/A Country:
United States
United States
Employees: N/A City: TEANECK
Market Cap: 521.3M IPO Year: 2014
Target Price: $18.50 AVG Volume (30 days): 142.0K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: 3.67% Dividend Payout Frequency: Quarterly
EPS: 0.37 EPS Growth: -58.89
52 Week Low/High: $9.40 - $15.98 Next Earning Date: 05-01-2024
Revenue: $982,014,000 Revenue Growth: 1.02%
Revenue Growth (this year): 4.2% Revenue Growth (next year): 3.24%

Share on Social Networks: